company background image
BIOX logo

Bioceres Crop Solutions NasdaqGS:BIOX Rapport sur les actions

Dernier prix

US$10.20

Capitalisation boursière

US$639.8m

7D

3.0%

1Y

-5.5%

Mise à jour

19 Aug, 2024

Données

Finances de l'entreprise +

Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Rapport sur les actions

Capitalisation boursière : US$639.8m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

BIOX Aperçu des actions

Bioceres Crop Solutions Corp. et ses filiales fournissent des solutions pour la productivité des cultures.

BIOX analyse fondamentale
Score flocon de neige
Évaluation1/6
Croissance future4/6
Performances passées2/6
Santé financière3/6
Dividendes0/6

Bioceres Crop Solutions Corp. Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Bioceres Crop Solutions
Historique des cours de bourse
Prix actuel de l'actionUS$10.20
Plus haut sur 52 semainesUS$14.05
Plus bas sur 52 semainesUS$9.71
Bêta0.47
1Variation sur 1 mois-8.68%
Variation sur 3 mois-8.19%
Variation sur 1 an-5.47%
3Variation sur 3 ans-24.28%
Variation sur 5 ans68.01%
Évolution depuis l'introduction en bourse108.16%

Nouvelles et mises à jour récentes

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Recent updates

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Rendement pour les actionnaires

BIOXUS ChemicalsUS Marché
7D3.0%3.0%4.9%
1Y-5.5%7.9%25.6%

Rendement vs Industrie: BIOX underperformed the US Chemicals industry which returned 7.3% over the past year.

Rendement vs marché: BIOX underperformed the US Market which returned 24.7% over the past year.

Volatilité des prix

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement4.0%
Chemicals Industry Average Movement5.8%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Cours de l'action stable: BIOX n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: BIOX's weekly volatility (4%) has been stable over the past year.

À propos de l'entreprise

FondéeSalariésPDGSite web
2001n/aFederico Truccobiocerescrops.com

Bioceres Crop Solutions Corp. et ses filiales fournissent des solutions pour la productivité des cultures. Elle opère par le biais des segments Semences et produits intégrés, Protection des cultures et Nutrition des cultures. Le segment Semences et produits intégrés fournit des traits de semences, des germplasmes et des packs de traitement de semences pour des cultures plus saines et à plus haut rendement.

Bioceres Crop Solutions Corp. Résumé des fondamentaux

Comment les bénéfices et les revenus de Bioceres Crop Solutions se comparent-ils à sa capitalisation boursière ?
BIOX statistiques fondamentales
Capitalisation boursièreUS$639.77m
Bénéfices(TTM)US$3.07m
Recettes(TTM)US$445.59m

209.0x

Ratio P/E

1.4x

Ratio P/S

Le site BIOX est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
BIOX compte de résultat (TTM)
RecettesUS$445.59m
Coût des recettesUS$271.99m
Marge bruteUS$173.60m
Autres dépensesUS$170.53m
Les revenusUS$3.07m

Derniers bénéfices déclarés

Mar 31, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)0.049
Marge brute38.96%
Marge bénéficiaire nette0.69%
Ratio dettes/capitaux propres69.7%

Quelles ont été les performances à long terme de BIOX?

Voir les performances historiques et les comparaisons